See All Slides - tctmd.com

Slides

Presentation TCT 2013

Antithrombin Therapy (GP IIb/IIIa inhibitors) in Patients with ACS and Those Undergoing PCI

Presenter: Sripal Bangalore

October 27, 2013

Presentation TCT 2013

Critical Examination of Current Clinical Outcomes with Best-in-Class Contemporary Permanent Polymer Metallic DES: Can New Devices Improve upon These Results?

Presenter: Ran Kornowski

October 27, 2013

Presentation TCT 2013

Status of the Self-Expanding and Balloon-Expandable Bioresorbable Scaffolds

Presenter: Michael Dake

October 27, 2013

Presentation TCT 2013

The Case for a Bioresorbable Polymeric Platform!

Presenter: Syed Hossainy

October 27, 2013

Presentation TCT 2013

ASD in the Elderly: Technical Approach and Results of Closure

Presenter: David Hildick-Smith

October 27, 2013

Presentation TCT 2013

TASTE: Essential Results and Methodology of a Randomized Registry Trial

Presenter: Ole Fr?bert

October 27, 2013

Presentation TCT 2013

Endovascular Management of Paget-Schroetter Syndrome

Presenter: Michael Wholey

October 27, 2013

Presentation TCT 2013

Thoughtful Commentary(2)

Presenter: David Hildick-Smith

October 27, 2013

Presentation TCT 2013

Niche Role, Given Their Less Forgiving Nature, Greater Cost, and Lack of Proven Clinical Benefit!

Presenter: David Hildick-Smith

October 27, 2013

Presentation TCT 2013

EPC Capture, Bioabsorbable Polymer Sirolimus DES: The Japan-US COMBO Study Plan

Presenter: Shigeru Saito

October 27, 2013

Advertisement

Slides

Antithrombin Therapy (GP IIb/IIIa inhibitors) in Patients with ACS and Those Undergoing PCI

Critical Examination of Current Clinical Outcomes with Best-in-Class Contemporary Permanent Polymer Metallic DES: Can New Devices Improve upon These Results?

Status of the Self-Expanding and Balloon-Expandable Bioresorbable Scaffolds

The Case for a Bioresorbable Polymeric Platform!

ASD in the Elderly: Technical Approach and Results of Closure

TASTE: Essential Results and Methodology of a Randomized Registry Trial

Endovascular Management of Paget-Schroetter Syndrome

Thoughtful Commentary(2)

Niche Role, Given Their Less Forgiving Nature, Greater Cost, and Lack of Proven Clinical Benefit!

EPC Capture, Bioabsorbable Polymer Sirolimus DES: The Japan-US COMBO Study Plan

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content